🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
🔴 Serious hazard — Reported risk: Das Produkt wurde nicht für den Verkauf an die breite Öffentlichkeit zugelassen. Das Produkt weist eine übermäßige Konzentration von Brodifacoum auf (Messwert: 0,05 g/kg Gewicht). Brodifacoum kann bei Verschlucken eine Hemmung der Blutgerinnung, Schäden an Blutgefäßen mit inneren Blutungen und Organschäden verursachen. Das Produkt entspricht nicht der Biozid-Verordnung noch der REACH-Verordnung.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Distributor
Category of measure
Ban on the marketing of the product and any accompanying measures
Date of entry into force
02/12/2025
Type of economic operator taking notified measure
Distributor
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): 2kg pellets brodifacoum
Risk Description (original English): The product has not been authorised for sale to the general public. The product has an excessive concentration of brodifacoum (measured value: 0.05 g/kg by weight). Brodifacoum can cause inhibition of blood clotting, damage to blood vessels leading to internal bleeding and organ damage in case of ingestion.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.